{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:35:06Z","timestamp":1791592506355,"version":"4.3.4"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["EU FP7"],"award-info":[{"award-number":["EU FP7"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["305815"],"award-info":[{"award-number":["305815"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["115770"],"award-info":[{"award-number":["115770"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013322","name":"EFPIA","doi-asserted-by":"publisher","award":["D-BOARD FP7"],"award-info":[{"award-number":["D-BOARD FP7"]}],"id":[{"id":"10.13039\/100013322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"IMI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["625746"],"award-info":[{"award-number":["625746"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011264","name":"FP7-PEOPLE","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011264","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003022","name":"IEF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003022","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004504","name":"Research Council of Lithuania","doi-asserted-by":"publisher","award":["3-LMT-K-712"],"award-info":[{"award-number":["3-LMT-K-712"]}],"id":[{"id":"10.13039\/501100004504","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004504","name":"Research Council of Lithuania","doi-asserted-by":"publisher","award":["3-LMT-K-712-01-0157"],"award-info":[{"award-number":["3-LMT-K-712-01-0157"]}],"id":[{"id":"10.13039\/501100004504","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004504","name":"Research Council of Lithuania","doi-asserted-by":"publisher","award":["DOTSUT-215"],"award-info":[{"award-number":["DOTSUT-215"]}],"id":[{"id":"10.13039\/501100004504","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004504","name":"Research Council of Lithuania","doi-asserted-by":"publisher","award":["2018\u20132022"],"award-info":[{"award-number":["2018\u20132022"]}],"id":[{"id":"10.13039\/501100004504","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.bcp.2019.02.037","type":"journal-article","created":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T16:33:42Z","timestamp":1551458022000},"page":"41-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":203,"special_numbering":"C","title":["Osteoarthritis phenotypes and novel therapeutic targets"],"prefix":"10.1016","volume":"165","author":[{"given":"Willem Evert","family":"Van Spil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Kubassova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Boesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7952-9297","authenticated-orcid":false,"given":"Anne-Christine","family":"Bay-Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6261-1286","authenticated-orcid":false,"given":"Ali","family":"Mobasheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10053","key":"10.1016\/j.bcp.2019.02.037_b0005","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(16)31678-6","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","author":"Disease","year":"2016","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.bcp.2019.02.037_b0010","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/acr.21898","article-title":"Lifetime risk and age at diagnosis of symptomatic knee osteoarthritis in the US","volume":"65","author":"Losina","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.bcp.2019.02.037_b0015","unstructured":"Institute of M. Relieving Pain in America : A Blueprint for Transforming Prevention, Care, Education, and Research. Washington, D.C.: National Academies Press, 2011."},{"issue":"7","key":"10.1016\/j.bcp.2019.02.037_b0020","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2522\/ptj.20120423","article-title":"Comparison of health-related quality of life, work status, and health care utilization and costs according to hip and knee joint disease severity: a national Australian study","volume":"93","author":"Ackerman","year":"2013","journal-title":"Phys. Ther."},{"issue":"10","key":"10.1016\/j.bcp.2019.02.037_b0025","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.joca.2015.05.029","article-title":"Projecting the direct cost burden of osteoarthritis in Canada using a microsimulation model","volume":"23","author":"Sharif","year":"2015","journal-title":"Osteoarth. Cartil."},{"issue":"1","key":"10.1016\/j.bcp.2019.02.037_b0030","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/BOR.0000000000000467","article-title":"Development and use of biochemical markers in osteoarthritis: current update","volume":"30","author":"Bay-Jensen","year":"2018","journal-title":"Curr. Opin. Rheumatol."},{"issue":"1","key":"10.1016\/j.bcp.2019.02.037_b0035","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/BOR.0000000000000567","article-title":"Molecular taxonomy of osteoarthritis for patient stratification, disease management and drug development: biochemical markers associated with emerging clinical phenotypes and molecular endotypes","volume":"31","author":"Mobasheri","year":"2019","journal-title":"Curr. Opin. Rheumatol."},{"issue":"2","key":"10.1016\/j.bcp.2019.02.037_b0040","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.joca.2017.11.013","article-title":"Are bisphosphonates efficacious in knee osteoarthritis? A meta-analysis of randomized controlled trials","volume":"26","author":"Vaysbrot","year":"2018","journal-title":"Osteoarth. Cartil."},{"issue":"7","key":"10.1016\/j.bcp.2019.02.037_b0045","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1002\/jor.23844","article-title":"Bone marrow lesions in osteoarthritis: what lies beneath","volume":"36","author":"Alliston","year":"2018","journal-title":"J. Orthop. Res."},{"issue":"4","key":"10.1016\/j.bcp.2019.02.037_b0050","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.cpet.2018.05.007","article-title":"MR imaging of joint infection and inflammation with emphasis on dynamic contrast-enhanced MR imaging","volume":"13","author":"Boesen","year":"2018","journal-title":"PET Clin."},{"issue":"9","key":"10.1016\/j.bcp.2019.02.037_b0055","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1136\/ard.2008.096834","article-title":"Change in MRI-detected subchondral bone marrow lesions is associated with cartilage loss: the MOST Study. A longitudinal multicentre study of knee osteoarthritis","volume":"68","author":"Roemer","year":"2009","journal-title":"Ann. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.bcp.2019.02.037_b0060","doi-asserted-by":"crossref","first-page":"541","DOI":"10.7326\/0003-4819-134-7-200104030-00007","article-title":"The association of bone marrow lesions with pain in knee osteoarthritis","volume":"134","author":"Felson","year":"2001","journal-title":"Ann. Intern. Med."},{"issue":"8","key":"10.1016\/j.bcp.2019.02.037_b0065","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1136\/annrheumdis-2011-200970","article-title":"Zoledronic acid reduces knee pain and bone marrow lesions over 1 year: a randomised controlled trial","volume":"71","author":"Laslett","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.bcp.2019.02.037_b0070","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12891-018-2143-2","article-title":"A protocol for a multicentre, randomised, double-blind, placebo-controlled trial to compare the effect of annual infusions of zoledronic acid to placebo on knee structural change and knee pain over 24 months in knee osteoarthritis patients \u2013 ZAP2","volume":"19","author":"Aitken","year":"2018","journal-title":"BMC Musculoskelet. Disord."},{"key":"10.1016\/j.bcp.2019.02.037_b0075","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/annrheumdis-2018-eular.1539","article-title":"OP0016 A multicentre randomised controlled trial of zoledronic acid for osteoarthritis of the knee with bone marrow lesions","volume":"77","author":"Cai","year":"2018","journal-title":"Ann. Rheumat. Dis."},{"issue":"2","key":"10.1016\/j.bcp.2019.02.037_b0080","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1136\/annrheumdis-2013-203989","article-title":"Disease-modifying effect of strontium ranelate in a subset of patients from the Phase III knee osteoarthritis study SEKOIA using quantitative MRI: reduction in bone marrow lesions protects against cartilage loss","volume":"74","author":"Pelletier","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.bcp.2019.02.037_b0085","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1136\/annrheumdis-2012-201458","article-title":"In erosive hand osteoarthritis more inflammatory signs on ultrasound are found than in the rest of hand osteoarthritis","volume":"72","author":"Kortekaas","year":"2013","journal-title":"Ann. Rheum. Dis."},{"issue":"10","key":"10.1016\/j.bcp.2019.02.037_b0090","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.joca.2009.04.020","article-title":"Ultrasonographic evidence of inflammation is frequent in hands of patients with erosive osteoarthritis","volume":"17","author":"Vlychou","year":"2009","journal-title":"Osteoarth. Cartil."},{"issue":"11","key":"10.1016\/j.bcp.2019.02.037_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.joca.2015.06.004","article-title":"Ultrasound detected inflammation is associated with the development of new bone erosions in hand osteoarthritis: a longitudinal study over 3.9 years","volume":"23","author":"Mancarella","year":"2015","journal-title":"Osteoarth. Cartil."},{"issue":"9","key":"10.1016\/j.bcp.2019.02.037_b0100","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1136\/annrheumdis-2013-205003","article-title":"Inflammatory ultrasound features show independent associations with progression of structural damage after over 2 years of follow-up in patients with hand osteoarthritis","volume":"74","author":"Kortekaas","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2019.02.037_b0105","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2018-213202","article-title":"Etanercept in patients with inflammatory hand osteoarthritis (EHOA): a multicentre, randomised, double-blind, placebo-controlled trial","author":"Kloppenburg","year":"2018","journal-title":"Ann. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.bcp.2019.02.037_b0110","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.joca.2018.02.899","article-title":"A randomised double-blind placebo-controlled crossover trial of HUMira (adalimumab) for erosive hand OsteoaRthritis - the HUMOR trial","volume":"26","author":"Aitken","year":"2018","journal-title":"Osteoarthr. Cartil."},{"issue":"3","key":"10.1016\/j.bcp.2019.02.037_b0115","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.joca.2015.09.013","article-title":"Synovitis and the risk of knee osteoarthritis: the MOST Study","volume":"24","author":"Felson","year":"2016","journal-title":"Osteoarth. Cartil."},{"issue":"10","key":"10.1016\/j.bcp.2019.02.037_b0120","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1136\/ard.2009.121426","article-title":"Relation of synovitis to knee pain using contrast-enhanced MRIs","volume":"69","author":"Baker","year":"2010","journal-title":"Ann. Rheum. Dis."},{"issue":"Suppl 2","key":"10.1016\/j.bcp.2019.02.037_b0125","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1136\/annrheumdis-2018-eular.2727","volume":"77","author":"Fleischmann","year":"2018","journal-title":"Ann. Rheumat. Dis."},{"key":"10.1016\/j.bcp.2019.02.037_b0130","article-title":"Can effusion-synovitis measured on ultrasound or MRI predict response to intra-articular steroid injection in hip osteoarthritis?","author":"Steer","year":"2018","journal-title":"Skeletal. Radiol."},{"issue":"1","key":"10.1016\/j.bcp.2019.02.037_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/rheumatology\/ket247","article-title":"Osteoarthritis: a progressive disease with changing phenotypes","volume":"53","author":"Castaneda","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.bcp.2019.02.037_b0140","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.joca.2013.10.020","article-title":"Identification and characterisation of osteoarthritis patients with inflammation derived tissue turnover","volume":"22","author":"Siebuhr","year":"2014","journal-title":"Osteoarth. Cartil."},{"key":"10.1016\/j.bcp.2019.02.037_b0145","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1016\/j.joca.2018.02.387","article-title":"C1M, C2M, C3M, PRO-C2, and CRPM in serum reflect different potential pathogenetic domains of osteoarthritis, data from check","volume":"26","author":"Bay-Jensen","year":"2018","journal-title":"Osteoarth. Cartil."},{"issue":"1","key":"10.1016\/j.bcp.2019.02.037_b0150","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12891-018-1955-4","article-title":"Serum and synovial fluid cytokine profiling in hip osteoarthritis: distinct from knee osteoarthritis and correlated with pain","volume":"19","author":"Ren","year":"2018","journal-title":"BMC Musculoskelet. Disord."},{"key":"10.1016\/j.bcp.2019.02.037_b0155","article-title":"Osteoarthritis year in review 2018: biomarkers (biochemical markers)","author":"Saberi Hosnijeh","year":"2018","journal-title":"Osteoarth. Cartil."},{"key":"10.1016\/j.bcp.2019.02.037_b0160","doi-asserted-by":"crossref","first-page":"S293","DOI":"10.1016\/j.joca.2018.02.589","article-title":"Results from a 52-week randomized, double-blind, placebo-controlled, phase 2 study of a novel, intra-articular wnt pathway inhibitor (SM04690) for the treatment of knee osteoarthritis","volume":"26","author":"Yazici","year":"2018","journal-title":"Osteoarth. Cartil."},{"issue":"suppl 10","key":"10.1016\/j.bcp.2019.02.037_b0165","article-title":"Efficacy and safety from a phase 2b trial of SM04690, a novel, intra-articular, wnt pathway inhibitor for the treatment of osteoarthritis of the knee [abstract]","volume":"70","author":"Yazici","year":"2018","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"10.1016\/j.bcp.2019.02.037_b0170","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12891-018-1938-5","article-title":"Identification of pain categories associated with change in pain in patients receiving placebo: data from two phase 3 randomized clinical trials in symptomatic knee osteoarthritis","volume":"19","author":"Bihlet","year":"2018","journal-title":"BMC Musculoskelet. Disord."},{"issue":"9","key":"10.1016\/j.bcp.2019.02.037_b0175","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.joca.2017.04.001","article-title":"Synovial fluid pro-inflammatory profile differs according to the characteristics of knee pain","volume":"25","author":"Leung","year":"2017","journal-title":"Osteoarth. Cartil."},{"issue":"9","key":"10.1016\/j.bcp.2019.02.037_b0180","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.joca.2013.05.017","article-title":"Structural correlates of pain in joints with osteoarthritis","volume":"21","author":"Hunter","year":"2013","journal-title":"Osteoarth. Cartil."},{"issue":"12","key":"10.1016\/j.bcp.2019.02.037_b0185","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.joca.2012.08.027","article-title":"Synovial inflammation, immune cells and their cytokines in osteoarthritis: a review","volume":"20","author":"de Lange-Brokaar","year":"2012","journal-title":"Osteoarth. Cartil."},{"issue":"11","key":"10.1016\/j.bcp.2019.02.037_b0190","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nrrheum.2010.159","article-title":"The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis","volume":"6","author":"Sellam","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"issue":"5","key":"10.1016\/j.bcp.2019.02.037_b0195","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1186\/s13075-014-0470-8","article-title":"Nociceptive neurons detect cytokines in arthritis","volume":"16","author":"Schaible","year":"2014","journal-title":"Arthritis Res. Ther."},{"issue":"2","key":"10.1016\/j.bcp.2019.02.037_b0200","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.joca.2016.10.006","article-title":"The association between histological, macroscopic and magnetic resonance imaging assessed synovitis in end-stage knee osteoarthritis: a cross-sectional study","volume":"25","author":"Riis","year":"2017","journal-title":"Osteoarth. Cartil."},{"issue":"6","key":"10.1016\/j.bcp.2019.02.037_b0205","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.ejrad.2016.03.017","article-title":"Synovitis assessed on static and dynamic contrast-enhanced magnetic resonance imaging and its association with pain in knee osteoarthritis: a cross-sectional study","volume":"85","author":"Riis","year":"2016","journal-title":"Eur. J. Radiol."},{"issue":"7","key":"10.1016\/j.bcp.2019.02.037_b0210","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.joca.2014.04.018","article-title":"Knee pain and inflammation in the infrapatellar fat pad estimated by conventional and dynamic contrast-enhanced magnetic resonance imaging in obese patients with osteoarthritis: a cross-sectional study","volume":"22","author":"Ballegaard","year":"2014","journal-title":"Osteoarth. Cartil."},{"key":"10.1016\/j.bcp.2019.02.037_b0215","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12891-016-1028-5","article-title":"Is there a role of synovial biopsy in drug development?","volume":"17","author":"Filkova","year":"2016","journal-title":"BMC Musculoskelet.Disord."},{"issue":"2","key":"10.1016\/j.bcp.2019.02.037_b0220","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/rheumatology\/40.2.158","article-title":"Morphological analysis of knee synovial membrane biopsies from a randomized controlled clinical study comparing the effects of sodium hyaluronate (Hyalgan) and methylprednisolone acetate (Depomedrol) in osteoarthritis","volume":"40","author":"Pasquali Ronchetti","year":"2001","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.bcp.2019.02.037_b0225","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1186\/s13075-014-0426-z","article-title":"Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy?","volume":"16","author":"van Baarsen","year":"2014","journal-title":"Arthritis Res. Ther."},{"issue":"9","key":"10.1016\/j.bcp.2019.02.037_b0230","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.joca.2016.04.010","article-title":"Direct in vivo evidence of activated macrophages in human osteoarthritis","volume":"24","author":"Kraus","year":"2016","journal-title":"Osteoarth. Cartil."},{"issue":"suppl_1","key":"10.1016\/j.bcp.2019.02.037_b0235","doi-asserted-by":"crossref","first-page":"i27","DOI":"10.1093\/rheumatology\/kex445","article-title":"Imaging tools to measure treatment response in gout","volume":"57","author":"Dalbeth","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.bcp.2019.02.037_b0240","article-title":"Update on imaging in gout: contrasting and comparing the role of dual-energy computed tomography to traditional diagnostic and monitoring techniques","author":"Bayat","year":"2018","journal-title":"Clin. Exp. Rheumatol"},{"issue":"4","key":"10.1016\/j.bcp.2019.02.037_b0245","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.rcl.2018.03.003","article-title":"Advanced musculoskeletal applications of dual-energy computed tomography","volume":"56","author":"Wong","year":"2018","journal-title":"Radiol. Clin. North. Am."},{"issue":"5","key":"10.1016\/j.bcp.2019.02.037_b0250","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.berh.2018.07.002","article-title":"Soluble biochemical markers of osteoarthritis: are we close to using them in clinical practice?","volume":"31","author":"Mobasheri","year":"2017","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.bcp.2019.02.037_b0255","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/BOR.0000000000000460","article-title":"What did we learn from 'omics' studies in osteoarthritis","volume":"30","author":"Ruiz-Romero","year":"2018","journal-title":"Curr. Opin. Rheumatol."},{"issue":"8","key":"10.1016\/j.bcp.2019.02.037_b0260","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3109\/1354750X.2015.1105499","article-title":"Applying computation biology and \u201cbig data\u201d to develop multiplex diagnostics for complex chronic diseases such as osteoarthritis","volume":"20","author":"Ren","year":"2015","journal-title":"Biomarkers"},{"issue":"Pt B","key":"10.1016\/j.bcp.2019.02.037_b0265","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.biocel.2016.08.016","article-title":"Comparative proteomics in alkaptonuria provides insights into inflammation and oxidative stress","volume":"81","author":"Braconi","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.bcp.2019.02.037_b0270","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/s41598-018-20132-7","article-title":"Automatic knee osteoarthritis diagnosis from plain radiographs: a deep learning-based approach","volume":"8","author":"Tiulpin","year":"2018","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bcp.2019.02.037_b0275","article-title":"Automatic segmentation of high- and low-field knee MRIs using knee image quantification with data from the osteoarthritis initiative","volume":"2","author":"Dam","year":"2015","journal-title":"J. Med. Imaging (Bellingham)"},{"key":"10.1016\/j.bcp.2019.02.037_b0280","article-title":"An efficient and fast computer-aided method for fully automated diagnosis of meniscal tears from magnetic resonance images","author":"Saygili","year":"2018","journal-title":"Artif. Intell. Med."},{"issue":"8","key":"10.1016\/j.bcp.2019.02.037_b0285","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.joca.2016.03.015","article-title":"Synovial volume vs synovial measurements from dynamic contrast enhanced MRI as measures of response in osteoarthritis","volume":"24","author":"Gait","year":"2016","journal-title":"Osteoarth. Cartil."},{"issue":"3","key":"10.1016\/j.bcp.2019.02.037_b0290","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1136\/annrheumdis-2013-204052","article-title":"A novel method for bone area measurement provides new insights into osteoarthritis and its progression","volume":"74","author":"Bowes","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2019.02.037_b0295","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s13075-015-0735-x","article-title":"A systematic review of the relationship between subchondral bone features, pain and structural pathology in peripheral joint osteoarthritis","volume":"17","author":"Barr","year":"2015","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.bcp.2019.02.037_b0300","doi-asserted-by":"crossref","first-page":"9280","DOI":"10.1038\/s41598-018-27486-y","article-title":"A new quantitative 3D approach to imaging of structural joint disease","volume":"8","author":"Turmezei","year":"2018","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.bcp.2019.02.037_b0305","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1016\/j.joca.2017.08.009","article-title":"Knee osteoarthritis phenotypes and their relevance for outcomes: a systematic review","volume":"25","author":"Deveza","year":"2017","journal-title":"Osteoarth. Cartil."},{"issue":"2","key":"10.1016\/j.bcp.2019.02.037_b0310","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/ard.2006.053538","article-title":"Body mass index associated with onset and progression of osteoarthritis of the knee but not of the hip: the Rotterdam Study","volume":"66","author":"Reijman","year":"2007","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.bcp.2019.02.037_b0315","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.drudis.2017.10.008","article-title":"Biochemical marker discovery, testing and evaluation for facilitating OA drug discovery and development","volume":"23","author":"Bay-Jensen","year":"2018","journal-title":"Drug Discov. Today."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295219300851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295219300851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:06:37Z","timestamp":1757768797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295219300851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":63,"alternative-id":["S0006295219300851"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2019.02.037","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Osteoarthritis phenotypes and novel therapeutic targets","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2019.02.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}